New study validates the prognostic value of the HER2DX test in HER2-positive breast cancer
Researchers from the Clínic Barcelona Comprehensive Cancer Center—driven by Hospital Clínic Barcelona, IDIBAPS, and the University of Barcelona—tog...
Researchers from the Clínic Barcelona Comprehensive Cancer Center—driven by Hospital Clínic Barcelona, IDIBAPS, and the University of Barcelona—tog...
On March 25, the IDIBAPS facilities hosted the Kick-off meeting of the European project "Evaluation and optimization of proton arc therapy" known b...
On Thursday 13 March 2025, IDIBAPS held the first meeting of the new research project ‘AECC-IDIBAPS Excellence Programme: Immunotherapy Against Can...
“I didn’t know what my present or my future would be like. I was very scared”, recalls Olga Federico of the time when she was diagnosed with breas...
On Monday 24 February, the Spanish Association Against Cancer (AECC) held a ceremony to announce the research grants awarded in Barcelona during 20...
